344 related articles for article (PubMed ID: 15446360)
1. The influence of the time of antidotal treatment administration on its effectiveness against tabun-induced poisoning in mice.
Kassa J
Acta Medica (Hradec Kralove); 2004; 47(2):111-4. PubMed ID: 15446360
[TBL] [Abstract][Full Text] [Related]
2. The influence of anticholinergic drug and oxime selection on the effectiveness of antidotal treatment against tabun-induced poisoning in mice.
Kassa J
Acta Medica (Hradec Kralove); 2002; 45(2):75-8. PubMed ID: 12325456
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
4. The influence of the time of antidotal treatment administration on the potency of newly developed oximes to counteract acute toxic effects of tabun in mice.
Kassa J
Acta Medica (Hradec Kralove); 2005; 48(2):87-90. PubMed ID: 16259318
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
Kassa J; Krejèová G
Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
[TBL] [Abstract][Full Text] [Related]
6. The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice.
Kassa J
Neurotox Res; 2006 Jan; 9(1):59-62. PubMed ID: 16464753
[TBL] [Abstract][Full Text] [Related]
7. [Effect of acetylcholinesterase reactivator dosage on its effectiveness in the treatment of tabun poisoning in mice].
Kassa J
Ceska Slov Farm; 2004 Jan; 53(1):31-4. PubMed ID: 15065394
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
Kassa J; Humlicek V
Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
[TBL] [Abstract][Full Text] [Related]
12. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
13. Anticholinergic drugs--functional antidotes for the treatment of tabun intoxication.
Krejcová G; Kassa J
Acta Medica (Hradec Kralove); 2004; 47(1):13-8. PubMed ID: 15168875
[TBL] [Abstract][Full Text] [Related]
14. The influence of oxime selection on the efficacy of antidotal treatment of soman-poisoned rats.
Kassa J; Fusek J
Acta Medica (Hradec Kralove); 2002; 45(1):19-27. PubMed ID: 12143107
[TBL] [Abstract][Full Text] [Related]
15. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of different antidotes on tabun-induced cognitive impairment in rats using water maze.
Kunesová G; Kassa J
Acta Medica (Hradec Kralove); 2006; 49(2):113-8. PubMed ID: 16956120
[TBL] [Abstract][Full Text] [Related]
17. Effect of methoxime combined with anticholinergic, anticonvulsant or anti-HCN drugs in tabun-poisoned mice.
Sevelová L; Vachek J
Acta Medica (Hradec Kralove); 2003; 46(3):109-12. PubMed ID: 14677719
[TBL] [Abstract][Full Text] [Related]
18. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
Kassa J; Karasova J
J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the potency of trimedoxime and other currently available oximes to reactivate tabun-inhibited acetylcholinesterase and eliminate acute toxic effects of tabun.
Kassa J; Kuca K; Cabal J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):419-23. PubMed ID: 16601802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
